Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110042329> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2110042329 endingPage "93" @default.
- W2110042329 startingPage "89" @default.
- W2110042329 abstract "Purpose: The purpose of this study was to report a patient with choroidal and optic disc metastases from breast cancer and the response to combination pharmacotherapy with tamoxifen, cyclophosphamide hydrate, letrozole, and bevacizumab. Methods: We report a case of a 51-year-old woman with a medical history of breast cancer treated with mastectomy at 16 years earlier followed by 5′-deoxy-5-fluorouridine and tamoxifen for 12 years, who has been followed by annual check-up, with no additional findings. Two weeks prior to her first visit to our hospital, she noted blurred and abnormal color vision and field loss in her right eye. Her right eye showed choroidal metastasis from breast cancer, with retinal detachment involving the macula and inferior periphery. Results: Multiple metastases involving bones, lymph nodes in the mediastinum, ovaries, and pelvic nodes were diagnosed after ocular metastases were established. Combination therapy with tamoxifen, cyclophosphamide hydrate, letrozole, and bevacizumab was administered to the patient. The retinal detachment and optic disc metastasis improved dramatically. Conclusions: The patient underwent combination pharmacotherapy with tamoxifen, cyclophosphamide hydrate, letrozole, and bevacizumab, which was effective in the treatment of ocular metastases from breast cancer." @default.
- W2110042329 created "2016-06-24" @default.
- W2110042329 creator A5017346480 @default.
- W2110042329 creator A5035799076 @default.
- W2110042329 creator A5054227468 @default.
- W2110042329 creator A5060972725 @default.
- W2110042329 creator A5062725691 @default.
- W2110042329 date "2012-02-01" @default.
- W2110042329 modified "2023-09-26" @default.
- W2110042329 title "Choroidal and Optic Disc Metastases from Breast Cancer and Their Response to Combination Pharmacotherapy with Tamoxifen, Cyclophosphamide Hydrate, Letrozole, and Bevacizumab" @default.
- W2110042329 cites W1596865488 @default.
- W2110042329 cites W1976184333 @default.
- W2110042329 cites W1981644244 @default.
- W2110042329 cites W1983244397 @default.
- W2110042329 cites W2013202228 @default.
- W2110042329 cites W2013703959 @default.
- W2110042329 cites W2025760976 @default.
- W2110042329 cites W2050023771 @default.
- W2110042329 cites W2055509475 @default.
- W2110042329 cites W2061548588 @default.
- W2110042329 cites W2082507486 @default.
- W2110042329 cites W2088921333 @default.
- W2110042329 doi "https://doi.org/10.1089/jop.2011.0098" @default.
- W2110042329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22011078" @default.
- W2110042329 hasPublicationYear "2012" @default.
- W2110042329 type Work @default.
- W2110042329 sameAs 2110042329 @default.
- W2110042329 citedByCount "7" @default.
- W2110042329 countsByYear W21100423292013 @default.
- W2110042329 countsByYear W21100423292014 @default.
- W2110042329 countsByYear W21100423292015 @default.
- W2110042329 countsByYear W21100423292017 @default.
- W2110042329 crossrefType "journal-article" @default.
- W2110042329 hasAuthorship W2110042329A5017346480 @default.
- W2110042329 hasAuthorship W2110042329A5035799076 @default.
- W2110042329 hasAuthorship W2110042329A5054227468 @default.
- W2110042329 hasAuthorship W2110042329A5060972725 @default.
- W2110042329 hasAuthorship W2110042329A5062725691 @default.
- W2110042329 hasConcept C121608353 @default.
- W2110042329 hasConcept C126322002 @default.
- W2110042329 hasConcept C141071460 @default.
- W2110042329 hasConcept C2776067312 @default.
- W2110042329 hasConcept C2776694085 @default.
- W2110042329 hasConcept C2776755627 @default.
- W2110042329 hasConcept C2777176818 @default.
- W2110042329 hasConcept C2777802072 @default.
- W2110042329 hasConcept C2778812593 @default.
- W2110042329 hasConcept C530470458 @default.
- W2110042329 hasConcept C71924100 @default.
- W2110042329 hasConceptScore W2110042329C121608353 @default.
- W2110042329 hasConceptScore W2110042329C126322002 @default.
- W2110042329 hasConceptScore W2110042329C141071460 @default.
- W2110042329 hasConceptScore W2110042329C2776067312 @default.
- W2110042329 hasConceptScore W2110042329C2776694085 @default.
- W2110042329 hasConceptScore W2110042329C2776755627 @default.
- W2110042329 hasConceptScore W2110042329C2777176818 @default.
- W2110042329 hasConceptScore W2110042329C2777802072 @default.
- W2110042329 hasConceptScore W2110042329C2778812593 @default.
- W2110042329 hasConceptScore W2110042329C530470458 @default.
- W2110042329 hasConceptScore W2110042329C71924100 @default.
- W2110042329 hasIssue "1" @default.
- W2110042329 hasLocation W21100423291 @default.
- W2110042329 hasLocation W21100423292 @default.
- W2110042329 hasOpenAccess W2110042329 @default.
- W2110042329 hasPrimaryLocation W21100423291 @default.
- W2110042329 hasRelatedWork W110384481 @default.
- W2110042329 hasRelatedWork W188673006 @default.
- W2110042329 hasRelatedWork W1986212317 @default.
- W2110042329 hasRelatedWork W2016809800 @default.
- W2110042329 hasRelatedWork W2041220146 @default.
- W2110042329 hasRelatedWork W2107764983 @default.
- W2110042329 hasRelatedWork W2110042329 @default.
- W2110042329 hasRelatedWork W2125589899 @default.
- W2110042329 hasRelatedWork W2148901112 @default.
- W2110042329 hasRelatedWork W2433539343 @default.
- W2110042329 hasVolume "28" @default.
- W2110042329 isParatext "false" @default.
- W2110042329 isRetracted "false" @default.
- W2110042329 magId "2110042329" @default.
- W2110042329 workType "article" @default.